BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

BXPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

BXPHARMA 13-Apr-2016

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 20, 2016 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2015.

BXPHARMA 03-Jan-2016

Credit Rating Information and Services Limited (CRISL) has rated the Company as "AA" in the long term and "ST - 2" in the short term along with a stable outlook based on audited financial statements of the Company up to December 31, 2014, unaudited financials up to September 30, 2015 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

BXPHARMA 27-Oct-2015

(Q3 Un - audited): EPS was Tk. 1.09 for July - September, 2015 as against Tk. 1.11 for July - September, 2014; EPS was Tk. 3.70 for January - September, 2015 as against Tk. 2.99 for January - September, 2014. NOCFPS was Tk. 3.56 for January - September, 2015 as against Tk. 4.07 for January - September, 2014. NAV per share was Tk. 56.84 as of September 30, 2015 and Tk. 55.85 as of September 30, 2014.

BXPHARMA 20-Oct-2015

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2015 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on September 30, 2015.

BXPHARMA 26-Jul-2015

(H/Y Un-audited): Profit after tax from Jan-15 to June-15 was Tk. 1,009.16 million with EPS of Tk. 2.61 as against Tk. 724.27 million and Tk. 1.88 respectively for the same period of the previous year. Whereas Profit after tax from April-15 to June-15 was Tk. 602.45 million with EPS of Tk. 1.56 as against Tk. 394.49 million and Tk. 1.02 respectively for the same period of the previous year.

BXPHARMA 12-Jul-2015

The Company has informed that the cash dividend for the year 2014 has been disbursed to the respective shareholders' Bank Accounts through Bangladesh Electronic Fund Transfer Network (BEFTN) System.

BXPHARMA 22-Jun-2015

The Company has informed that it has credited the bonus shares for the year ended on December 31, 2014 to the respective shareholders' BO Account on June 22, 2015.

BXPHARMA 21-May-2015

Normal trading of the shares of the Company will resume on 24.05.2015 after record date.

BXPHARMA 20-May-2015

Trading of the shares of the Company will remain suspended on record date i.e., 21.05.2015.

BXPHARMA 18-May-2015

Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 19.05.2015 to 20.05.2015. Trading of the shares of the Company will remain suspended on record date i.e., 21.05.2015.

Previous Next page